MicroRNAs are predicted to regulate thousands of mammalian genes, but relatively few targets have been experimentally validated and few microRNA loss-of-function phenotypes have been assigned. As an alternative to chemically modified antisense oligonucleotides, we developed microRNA inhibitors that can be expressed in cells, as RNAs produced from transgenes. Termed 'microRNA sponges', these competitive inhibitors are transcripts expressed from strong promoters, containing multiple, tandem binding sites to a microRNA of interest. When vectors encoding these sponges are transiently transfected into cultured cells, sponges derepress microRNA targets at least as strongly as chemically modified antisense oligonucleotides. They specifically inhibit microRNAs with a complementary heptameric seed, such that a single sponge can be used to block an entire microRNA seed family. RNA polymerase II promoter (Pol II)-driven sponges contain a fluorescence reporter gene for identification and sorting of spongetreated cells. We envision the use of stably expressed sponges in animal models of disease and development.MicroRNAs are 20-24-nucleotide RNAs derived from hairpin precursors. Through pairing with partially complementary sites in 3′ untranslated regions (UTRs), they mediate posttranscriptional silencing of a predicted 30% of protein-coding genes in mammals 1 . MicroRNAs have been implicated in critical processes including differentiation, apoptosis, proliferation, and the maintenance of cell and tissue identity; furthermore, their misexpression has been linked to cancer and other diseases [2][3][4][5][6][7] . But relatively few micro-RNA-target interactions have been experimentally validated in cell culture or in mouse models, and the functions of most microRNAs remain to be discovered. Creating genetic knockouts to determine the function of microRNA families is difficult, as individual microRNAs expressed from multiple genomic loci may repress a common set of targets containing a complementary seed sequence. Thus, a method for inhibiting these functional classes of paralogous micro-RNAs in vivo is needed. Presently, loss-of-function phenotypes are induced by means of chemically modified antisense oligonucleotides-2′ O-methyl, locked nucleic acid (LNA) and others-which are presumed to pair with and block mature microRNAs through extensive sequence complementarity [8][9][10] . Typically, oligonucleotide